TAKEDA-C13002

Study Sponsor : Takeda

Study Title

Phase 2, Randomized, Placebo-Controlled, Double-Blind Label Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MLN0002 Following Multiple Intravenous Doses in Patients With Ulcerative Colitis

Medicine or Vaccine (generic name)

vedolizumab

Sponsor Identification Number

C13002

Trial Registry Identification Number(#'s)

NCT01177228

Medical Condition

Ulcerative Colitis; Crohn's Disease

Phase

Phase 2

Link to study details on the Takeda Clinical Study Register

http://takedaclinicaltrials.com/browse/summary/C13002

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/show/NCT01177228

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

October 2014